{"organizations": [], "uuid": "2232a0099137397512d2da917787e638ee22068d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-acerus-enters-into-licensing-agree/brief-acerus-enters-into-licensing-agreement-with-innovus-to-commercialize-urivarx-in-canada-idUSASB0BZZW", "country": "US", "domain_rank": 408, "title": "BRIEF-Acerus Enters Into Licensing Agreement With Innovus To Commercialize Urivarx In Canada", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-08T13:13:00.000+02:00", "replies_count": 0, "uuid": "2232a0099137397512d2da917787e638ee22068d"}, "author": "", "url": "https://www.reuters.com/article/brief-acerus-enters-into-licensing-agree/brief-acerus-enters-into-licensing-agreement-with-innovus-to-commercialize-urivarx-in-canada-idUSASB0BZZW", "ord_in_thread": 0, "title": "BRIEF-Acerus Enters Into Licensing Agreement With Innovus To Commercialize Urivarx In Canada", "locations": [], "entities": {"persons": [{"name": "uri", "sentiment": "negative"}, {"name": "innovus", "sentiment": "none"}], "locations": [{"name": "canada", "sentiment": "none"}, {"name": "canada", "sentiment": "none"}], "organizations": [{"name": "acerus pharmaceuticals corporation", "sentiment": "none"}, {"name": "in canada reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 13 AM / in 9 minutes BRIEF-Acerus Enters Into Licensing Agreement With Innovus To Commercialize Urivarx In Canada Reuters Staff \nJan 8 (Reuters) - Acerus Pharmaceuticals Corporation : \n* ACERUS ENTERS INTO A LICENSING AGREEMENT WITH INNOVUS TO COMMERCIALIZE URIVARX® IN CANADA \n* ACERUS PHARMACEUTICALS CORPORATION - ‍INNOVUS WILL OVERSEE MANUFACTURING OF URIVARX AND WILL RECEIVE A SUPPLY PRICE FOR PRODUCT​ \n* ACERUS PHARMACEUTICALS CORPORATION - ‍ UNDER TERMS OF EXCLUSIVE DISTRIBUTOR AND LICENSE AGREEMENT, INNOVUS WILL RECEIVE A PAYMENT AT SIGNING​ \n* ACERUS PHARMACEUTICALS - ‍ UNDER TERMS, INNOVUS TO ALSO RECEIVE MILESTONE PAYMENTS BASED ON ACERUS ACHIEVING CERTAIN SALES TARGETS​    ", "external_links": [], "published": "2018-01-08T13:13:00.000+02:00", "crawled": "2018-01-08T13:28:40.008+02:00", "highlightTitle": ""}